Brief: Oncosec Announces Pipeline Prioritization And Workforce Reduction

OncoSec Medical Incorporated

04/10/2022 22:52

Oct 4 (Reuters) - OncoSec Medical Inc  ONCS.O :
    * ONCOSEC- RESULTS OF PHASE 2B KEYNOTE-695 TRIAL SECONDARY
ENDPOINT, ORR BY INVESTIGATOR ASSESSMENT, EXPECTED TO BE
ANNOUNCED IN Q4 
    * ONCOSEC- RESULTS OF PHASE 2B KEYNOTE-695 TRIAL PRIMARY
ENDPOINT,
OVERALL ORR BY BICR, EXPECTED TO BE ANNOUNCED IN Q1 2023
    * ONCOSEC ANNOUNCES PIPELINE PRIORITIZATION AND WORKFORCE
REDUCTION
    * ONCOSEC MEDICAL INC - REDUCING ITS STAFF BY APPROXIMATELY
45%
    * ONCOSEC MEDICAL INC - IS REDUCING ITS STAFF BY
APPROXIMATELY 45%
AND PRIORITIZING CLINICAL PIPELINE ACTIVITIES TO REDUCE
OPERATING EXPENSES

Further company coverage:  ONCS.O 
 ((Reuters.Briefs@thomsonreuters.com;))